AngioDynamics Reports Strong Q3 Earnings

Got story updates? Submit your updates here. ›

AngioDynamics, a leading medical technology company, has reported its fiscal year 2026 third quarter financial results, showcasing a period of sustained double-digit growth across its product portfolio. The company's performance highlights the continued demand for its innovative medical devices and solutions in the healthcare market.

Why it matters

AngioDynamics' strong quarterly results demonstrate the company's ability to capitalize on the growing need for advanced medical technologies, particularly as the healthcare industry continues to evolve. The company's performance is a positive indicator for the broader medical device sector and its ability to drive innovation and growth.

The details

In the third quarter, AngioDynamics reported a 12% year-over-year increase in revenue, driven by robust demand for its minimally invasive surgical products and image-guided therapy solutions. The company's focus on developing cutting-edge technologies and expanding its product offerings has enabled it to maintain a competitive edge in the market.

• AngioDynamics reported its fiscal year 2026 third quarter financial results on April 2, 2026.

What they’re saying